SC 13G
DESIGN THERAPEUTICS, INC.
- Company
- Design Therapeutics, Inc.
- Filed
- April 3, 2023
- Accession Number
- 0001104659-23-040937
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →